Last €130.36 EUR
Change Today -2.06 / -1.56%
Volume 27.0
AG4 On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 12:18 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey L. Edwards

Non-Executive Officer, Allergan Inc.
AgeTotal Calculated CompensationThis person is connected to 2 board members in 1 different organizations across 5 different industries.

See Board Relationships
53$3,064,560
As of Fiscal Year 2013

Background*

Mr. Jeffrey L. Edwards, also known as Jeff, serves as the Chief Financial Officer and Vice President of Allergan USA, Inc. Mr. Edwards served as the Chief Financial Officer and Executive Vice President of Finance & Business Development at Allergan Inc. since September 5, 2005 until August 2014. Mr. Edwards served as Corporate Vice President of Corporate Development of Allergan Inc. from March 2003 to September 2005 and its Senior Vice President of Treasury, Tax & Investor ...

Read Full Background

Corporate Headquarters*

2525 Dupont Drive
Irvine, California 92612

United States

Phone: 714-246-4500
Fax: 714-246-6987

Board Members Memberships*

Former Observer and Director
2002-2004
Former Director
2013-Present
Director

Education*

BA 1982
Muhlenberg College

Other Affiliations*

Annual Compensation*

Salary$641,538
Total Annual Compensation$641,538

Stock Options*

All Other Compensation$38,105
Exercised Options153,200
Exercised Options Value$6,862,362
Exercisable Options273,600
Exercisable Options Value$13,174,008
Unexercisable Options185,400
Unexercisable Options Value$4,300,105
Total Value of Options$24,336,475
Total Number of Options612,200

Total Compensation*

Total Annual Cash Compensation$1,161,443
Total Short Term Compensation$641,538
Other Long Term Compensation$38,105
Total Calculated Compensation$3,064,560
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AG4:GR €130.36 EUR -2.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALLERGAN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.